-
Study aim
-
Evaluation and comparison of two xenografts in maxillary sinus augmentation
-
Design
-
Controlled randomized clinical trial, double blind, parallel group design of 12 patients. Coin toss will be used for randomization.
-
Settings and conduct
-
The present study will be performed at the periodontics department, Shahid Beheshti Dental School for patients who need an implant in the posterior maxilla. Tomographic radiographs are obtained and if the distance between the alveolar ridge and the floor of the maxillary sinus is less than 5 mm, they will enter the study after obtaining an informed consent. Randomization is done by tossing coins on the day of surgery. Patients are unaware of the type of grafting material used on each side of the mouth. Blinding will be performed for individuals performing clinical, radiographic, and histological evaluation.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: > 18 years, good general health, inadequate bone for a standard implant (< 5 mm residual alveolar bone height to the maxillary sinus floor), absence of infection or periapical lesion
Exclusion criteria: smoking, O'Leary plaque index > 20%, allergy to the material used in the study, pregnancy/ lactation, uncontrolled periodontal disease, systemic disease or intake of any medication, history of sinusitis or any pathologic condition in the sinus
-
Intervention groups
-
The "intervention group" consists of the use of Bone+ (Novateb Pars, Iran) on one side and the "control group" includes the use of OCS-B (Nibec Co., Korea) on the other side of the mouth of each participant for lateral window maxillary sinus augmentation.
-
Main outcome variables
-
Sinus augmentation volume; New bone formation; Residual material; Inflammation rate; Type of inflammation; Granulation tissue; Necrotic tissue; Giant cell